BIOLASE Reports 2015 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Biolase (BIOL) Misses Q2 EPS by 4c
August 5, 2015 4:55 PM EDTBiolase (NASDAQ: BIOL) reported Q2 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $12.3 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
... More


